Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes

Overview of attention for article published in Blood Advances, December 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 7 X users

Readers on

mendeley: 54 Mendeley

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 22,512 followers.

@HenrychihangFu1 It's been documented before that about 15% of these patients have MLL/KMT2A https://t.co/8BSZ6AUQbI

@AaronGoodman33 @ClarkCutrer @TalhaBadarMD @THilalMD @beatalleukemia @Dr_AmerZeidan @AshKishtagari @DrBattiwalla @BldCancerDoc Would you consider allo since looks like therapy related ALL? https://t.co/y63wrzEaPS

#throwback to work led by @CanerSaygin featuring @DrWendyStock & Dr Larson helping to define the entity of therapy-related ALL #leusm https://t.co/43sdU5nf45 https://t.co/SjEWlukv9z

RT @Anand_88_Patel: Day 4: therapy-related ALL (t-ALL) Multi-center analysis by @CanerSaygin @AshKishtagari & colleagues, worse outcomes i…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 3 additional X posts.